Yang Xinmin, Yao Linbo, Yuan Mei, Zhang Xiaoying, Jakubowska Monika A, Ferdek Pawel E, Dai Lei, Yang Jingyu, Jin Tao, Deng Lihui, Fu Xianghui, Du Dan, Liu Tingting, Criddle David N, Sutton Robert, Huang Wei, Xia Qing
Department of Integrated Traditional Chinese and Western Medicine, Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China.
Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Front Pharmacol. 2022 Jun 8;13:896523. doi: 10.3389/fphar.2022.896523. eCollection 2022.
Obesity-related acute pancreatitis (AP) is characterized by increasing prevalence worldwide and worse clinical outcomes compared to AP of other etiologies. Chaiqin chengqi decoction (CQCQD), a Chinese herbal formula, has long been used for the clinical management of AP but its therapeutic actions and the underlying mechanisms have not been fully elucidated. This study has investigated the pharmacological mechanisms of CQCQD in a novel mouse model of obesity-related alcohol-induced AP (OA-AP). The mouse OA-AP model was induced by a high-fat diet for 12 weeks and subsequently two intraperitoneal injections of ethanol, CQCQD was administered 2 h after the first injection of ethanol. The severity of OA-AP was assessed and correlated with changes in transcriptomic profiles and network pharmacology in the pancreatic and adipose tissues, and further docking analysis modeled the interactions between compounds of CQCQD and their key targets. The results showed that CQCQD significantly reduced pancreatic necrosis, alleviated systemic inflammation, and decreased the parameters associated with multi-organ dysfunction. Transcriptomics and network pharmacology analysis, as well as further experimental validation, have shown that CQCQD induced Nrf2/HO-1 antioxidant protein response and decreased Akt phosphorylation in the pancreatic and adipose tissues. , CQCQD protected freshly isolated pancreatic acinar cells from HO-elicited oxidative stress and necrotic cell death. The docking results of AKT1 and the active compounds related to AKT1 in CQCQD showed high binding affinity. In conclusion, CQCQD ameliorates the severity of OA-AP by activating of the antioxidant protein response and down-regulating of the PI3K/Akt signaling pathway in the pancreas and visceral adipose tissue.
肥胖相关性急性胰腺炎(AP)在全球范围内的发病率呈上升趋势,与其他病因引起的AP相比,其临床预后更差。柴芩承气汤(CQCQD)是一种中药方剂,长期以来一直用于AP的临床治疗,但其治疗作用和潜在机制尚未完全阐明。本研究在一种新型的肥胖相关性酒精诱导的AP(OA-AP)小鼠模型中研究了CQCQD的药理机制。通过高脂饮食12周,随后腹腔注射两次乙醇诱导小鼠OA-AP模型,在首次注射乙醇后2小时给予CQCQD。评估OA-AP的严重程度,并将其与胰腺和脂肪组织中转录组图谱和网络药理学的变化相关联,进一步的对接分析模拟了CQCQD化合物与其关键靶点之间的相互作用。结果表明,CQCQD显著减轻胰腺坏死,减轻全身炎症,并降低与多器官功能障碍相关的参数。转录组学和网络药理学分析以及进一步的实验验证表明,CQCQD诱导胰腺和脂肪组织中Nrf2/HO-1抗氧化蛋白反应并降低Akt磷酸化。此外,CQCQD保护新鲜分离的胰腺腺泡细胞免受HO诱导的氧化应激和坏死性细胞死亡。AKT1与CQCQD中与AKT1相关的活性化合物的对接结果显示出高结合亲和力。总之,CQCQD通过激活胰腺和内脏脂肪组织中的抗氧化蛋白反应并下调PI3K/Akt信号通路来改善OA-AP的严重程度。